Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edris Badreddin Insider Profile
4 Followers
Edris Badreddin, COO at Springworks Therapeutics, holds 229.60K shares in Springworks Therapeutics (Ticker: SWTX), holds ― shares in Edgewise Therapeutics (Ticker: EWTX).
Edris Badreddin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Edris Badreddin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Edris Badreddin
Edris Badreddin's Trading History
Springworks Therapeutics
Sep 04, 2024
COO
Uninformative Sell
812.86K
$8.33M
Edgewise Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Edris Badreddin's performance on stock
You May Also Like
Edris Badreddin insider profile FAQ
What is the percentage of profitable transactions made by Edris Badreddin?
The percentage of profitable transactions made by Edris Badreddin is ―.
What is the average return per transaction made by Edris Badreddin?
The average return per transaction made by Edris Badreddin is ―.
What stocks does Edris Badreddin hold?
Edris Badreddin holds: SWTX, EWTX stocks.
What was Edris Badreddin’s latest transaction?
Edris Badreddin latest transaction was an Uninformative Sell of $812.86K.
What was Edris Badreddin's most profitable transaction?
Edris Badreddin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Edris Badreddin's role in Springworks Therapeutics?
Edris Badreddin's role in Springworks Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.